Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiac Catheterization III: Left Heart Catheterization

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiac Catheterization II: Right Heart Catheterization

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Women Planned for Immediate Lymphatic Reconstruction During Axillary Lymph Node Dissection Should Be Reconstructable: Improving Intraoperative Team Collaboration.

Plastic surgery (Oakville, Ont.)·2025

Same author

Timing and method of manganese supplementation effects thermal resilience of Acropora millepora.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine·2025

Same author

An implementation science study of a campus-based drug checking service at a Canadian university.

PloS one·2025

Same author

The Effect of Preoperative Anemia on Blood Transfusion Outcomes in Major Head and Neck Cancer Surgery.

Cancers·2025

Same author

Millions Saved in Head and Neck Free Flap Reconstruction at a High-Volume Center: A Cost Analysis.

Plastic surgery (Oakville, Ont.)·2024

Same author

Advancing patient-centered metrics for heart transplantation: The role of days alive and outside the hospital.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2024

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Patient selection for left ventricular assist devices.

Lars H Lund¹, Jennifer Matthews, Keith Aaronson

¹Department of Cardiology, Section for Heart Failure, Karolinska University Hospital, N305 171 76 Stockholm, Sweden. lars.lund@alumni.duke.edu

European Journal of Heart Failure

|February 23, 2010

Summary

This summary is machine-generated.

Left ventricular assist devices (LVADs) offer improved outcomes for advanced heart failure (HF) patients, potentially matching heart transplantation (HTx). Careful patient selection is crucial for optimizing LVAD therapy success.

More Related Videos

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Related Experiment Videos

Last Updated: Jun 16, 2026

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Area of Science:

Cardiology
Medical Devices
Heart Failure Management

Background:

Heart transplantation (HTx) is limited by organ availability for advanced heart failure (HF).
Implantable left ventricular assist devices (LVADs) have seen significant technical advancements and improved patient outcomes.
LVADs are now established options for HF management, including bridge to transplantation, destination therapy, and bridge to recovery.

Purpose of the Study:

To review recent findings on predictors of poor outcomes in LVAD therapy.
To provide an overview of patient selection criteria for LVAD implantation.
To discuss the evolving role of LVADs in end-stage heart failure management.

Main Methods:

Review of recent scientific literature and clinical reports.
Analysis of studies identifying predictors of adverse outcomes in LVAD recipients.
Synthesis of current guidelines and consensus statements on LVAD patient selection.

Main Results:

Patient selection is identified as a critical factor for improving LVAD outcomes.
Emerging data suggests LVADs may soon rival or surpass HTx in efficacy for select patients.
Predictors of poor outcomes are being increasingly identified, aiding in refined patient selection.

Conclusions:

LVAD therapy represents a significant advancement in managing end-stage heart failure.
Optimizing patient selection is paramount to maximizing the benefits of LVADs.
Further research and updated guidelines are needed to navigate the rapidly evolving field of mechanical circulatory support.